We are proud to be listed among the top law firms in the 2022 Chambers and Partners Europe Pharma & Life Sciences Rankings.
What the firm is known for: De Gaulle Fleurance & Associés advises both domestic and international healthcare and pharmaceutical clients, often assisting with regulatory advice. The team acts on the implementation of procurement regulation and data privacy. The law firm also offers assistance with corporate matters, including the negotiation of contracts and collaboration agreements.
Clients highlight that the lawyers “are close to their client and have a business-oriented mindset.”
Jean-Marie Job et Cécile Théard-Jallu are once again listed as individual in the Pharma/Life Sciences: Regulatory rankings
“Prominent lawyer” Jean-Marie Job assists healthcare and biotechnology clients with complex regulatory mandates. His expertise includes advising on data protection issues, as well as contractual matters. A client comments that he is “extremely competent, has a wide and deep knowledge of health legal aspects and also very deep insights into business issues.”
Cécile Theard-Jallu assists technology companies, pharmaceutical firms, professional bodies and governmental agencies operating in the healthcare sector. She acts on a range of regulatory and IT mandates, including data protection and artificial intelligence issues. “She is pleasant, efficient and reassuring” says one client.
Our law firm is present each year in the international reference ranking guides: Chambers, Legal 500, Best Lawyers and Leaders League. We are proud of the results achieved collectively and individually by some of our lawyers. These rankings are based on the opinions of our clients, partners and peers – and on the quality of the services provided daily by our lawyers, paralegals and support staff.
Metaverse and medical devices: what are the legal issues?
“In 2021, Mark Zuckerberg’s ambition was to bring internet users into the metav...
Unified Patent Court and Unitary Patent: major changes for Patent litigation and licensing in Europe
Unified Patent Court and Unitary Patent: major changes for Patent litigation and lice...
